Search Results 921-930 of 15973 for anti-TNF drugs
About this study. Membranous glomerulopathy (MN) is still the most common glomerular disease associated with nephrotic proteinuria (NS).
About this study. Drug monitoring of Pembrolizumaband Nivolumab for determining the pharmacokinetic (PK) profile of these medications and to provide ...
A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from ...
... drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the ...
The purpose of this study is to evaluate whether or not treatment with alternating 17B-estradiol / anti-estrogen therapies on a defined 8-week / 16-week ...
Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...
Participation eligibility · Any approved anti-cancer therapy within 3 weeks prior to initiation of study treatment · Treatment with any other investigational ...
... therapy derived from donor peripheral blood, in combination with rituximab, monoclonal anti-CD20 antibody, for patients with relapsed or refractory B Cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.